Aggressive prostate myxoid mesenchymal neoplasm with novel CRTC1::NCOA2 fusion.

Tay, Wan Jing; Jeyasekharan, Anand; Goh, Jian Yuan; Chang, Kenneth Tou En; Kesavan, Arshvin; Lee, Victor K

Tay, Wan Jing; Jeyasekharan, Anand; Goh, Jian Yuan; Chang, Kenneth Tou En; Kesavan, Arshvin; Lee, Victor K.

Afiliación

Tay WJ; Department of Pathology, National University Hospital (NUH) Singapore, Singapore, Singapore.
Jeyasekharan A; National University Cancer Institute, Singapore (NCIS), National University Hospital (NUH), Singapore, Singapore.
Goh JY; Department of Pathology and Laboratory Medicine, KK Women's and Children's Hospital, Singapore, Singapore.
Chang KTE; Pathology Academic Clinical Programme, SingHealth Duke-NUS Medical School, Singapore, Singapore.
Kesavan A; Department of Pathology and Laboratory Medicine, KK Women's and Children's Hospital, Singapore, Singapore.
Lee VK; Department of Urology, National University Hospital (NUH) Singapore, Singapore, Singapore.

Histopathology ; 84(5): 909-912, 2024 Apr.

Article en En | MEDLINE | ID: mdl-38173295

Asunto(s)

Neoplasias; Próstata; Masculino; Humanos; Próstata/metabolismo; Factores de Transcripción/genética; Biomarcadores de Tumor; Coactivador 2 del Receptor Nuclear/genética; Proteínas de Fusión Oncogénica/genética; Fusión Génica

Palabras clave

CRTC1::NCOA2; myxoid mesenchymal neoplasm; novel gene fusion; prostate neoplasm

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Próstata / Neoplasias Límite: Humans / Male Idioma: En Revista: Histopathology Año: 2024 Tipo del documento: Article País de afiliación: Singapur

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google